The estrogen in birth control amplifies the contraceptive effect of the other hormone in the pill (progestin), stabilizes your uterine lining to prevent irregular bleeding, and contributes to several non-contraceptive benefits like clearer skin and bone protection. While progestin does most of the heavy lifting to prevent pregnancy, estrogen is what makes combined birth control more reliable, more predictable, and more tolerable than progestin-only methods.
How Estrogen Helps Prevent Ovulation
Your body normally releases a surge of two key hormones from the brain, FSH and LH, to trigger an egg to mature and release each month. The estrogen in birth control creates artificially high hormone levels that signal your brain to stop producing those surges. Without FSH driving follicle growth, no dominant egg develops. Without the LH surge, ovulation doesn’t happen.
Progestin is the primary driver of this suppression, but estrogen reinforces it. In primate studies, estrogen specifically inhibits the growth of developing follicles by reducing FSH secretion. Think of it as a backup system: progestin blocks ovulation through one pathway, and estrogen strengthens that block through another. This is why combined pills (estrogen plus progestin) tend to be slightly more effective than progestin-only pills, which rely on a single mechanism.
Controlling Your Bleeding Pattern
This is arguably where estrogen earns its place in the pill. During the active pill phase, the combination of estrogen and progestin keeps your uterine lining thin, stable, and less blood-rich than it would be in a natural cycle. Progestin counteracts estrogen’s natural tendency to thicken the lining, and together they maintain a controlled, compressed endometrium that doesn’t shed unpredictably.
When you hit the placebo week (or hormone-free interval), the sudden drop in both estrogen and progestin triggers the blood vessels supplying your uterine lining to constrict and then dilate. This causes the superficial layer to detach, producing the withdrawal bleed that resembles a period. That predictable, lighter bleed is a direct result of the estrogen-progestin balance during the active weeks. Without estrogen, progestin-only methods often cause irregular spotting because the lining becomes fragile and sheds in small, unpredictable patches.
When estrogen levels fluctuate or are too high relative to progestin, the lining can overgrow beyond what its support structure can handle. The glands outpace the surrounding tissue, blood vessels become fragile, and small areas break down randomly, causing breakthrough spotting. This is why getting the estrogen dose right matters for bleeding control.
Benefits Beyond Pregnancy Prevention
Estrogen-containing birth control is frequently prescribed for acne, excess hair growth, painful periods, and heavy menstrual bleeding. The skin benefits come partly from how estrogen increases production of a protein that binds to testosterone in your blood, lowering the amount of free testosterone available to stimulate oil glands and hair follicles. One comparison study found that pills containing the synthetic estrogen ethinyl estradiol increased this binding protein by 385%, dramatically reducing the free androgen index. Pills with a more natural form of estrogen (estradiol valerate) increased it by a more modest 56%.
Estrogen also plays a protective role in bone health. It slows bone breakdown by promoting the death of cells that dissolve bone tissue while keeping bone-building cells alive longer. In mature, premenopausal women, combined pill use has generally shown either a positive effect or no effect on bone density and fracture rates. A review of 13 studies in women over 30 found a positive bone effect in 9 and no effect in 4. The picture is less clear for teenagers, whose skeletons are still developing, though transdermal estrogen (delivered through a patch) has shown promising bone-building effects in adolescents.
How Estrogen Doses Have Changed
The first birth control pills in the 1960s contained 100 to 175 micrograms of estrogen. Today, most pills contain far less. Current formulations fall into a few tiers:
- Standard dose: 50 micrograms of ethinyl estradiol
- Low dose: 30 micrograms
- Very low dose: 20 micrograms
- Ultra-low dose: 15 or even 10 micrograms
This reduction happened because early pills caused significantly more cardiovascular side effects, and researchers discovered that much lower estrogen doses could still do the job. Most prescriptions today use pills with less than 50 micrograms, which are substantially safer than the original formulations.
Not All Estrogens Are the Same
Most combined pills use ethinyl estradiol, a potent synthetic estrogen that has been the standard for decades. But newer pills use different forms. Estradiol valerate is chemically closer to the estrogen your body produces naturally, and it has a milder effect on the liver. Compared to ethinyl estradiol, it suppresses FSH less aggressively (27% reduction vs. 64%) and triggers far less production of liver proteins like the testosterone-binding protein mentioned earlier. This milder profile may translate to fewer metabolic side effects, though it also means slightly less androgen suppression for acne.
An even newer option, estetrol, is a naturally occurring estrogen originally produced by the fetal liver during pregnancy. It’s designed to act selectively, providing enough activity to stabilize the lining and support contraception while potentially carrying lower cardiovascular risk. These newer estrogens represent an ongoing effort to keep the benefits of combined birth control while reducing the risks tied to the estrogen component.
The Blood Clot Risk
Estrogen is the primary reason combined birth control carries a higher risk of blood clots (venous thromboembolism) than progestin-only methods. It increases the production of clotting factors in the liver, tipping the balance toward clot formation. The baseline risk for women not using hormonal contraception is about 2 events per 10,000 person-years. With combined pills, that rises to roughly 5 to 16 per 10,000 depending on the specific formulation.
Lower estrogen doses reduce this risk. A large 2024 study published in JAMA found that pills with 20 micrograms of ethinyl estradiol paired with levonorgestrel had a rate of about 5 per 10,000 person-years, while pills with 30 to 40 micrograms of the same estrogen paired with other progestins ranged from about 7.6 to 16.2 per 10,000. Pills using estradiol (the more natural form) at lower doses showed a rate of about 5 per 10,000, similar to the lowest-risk synthetic formulations. To put this in perspective, pregnancy itself carries a clot risk of roughly 5 to 20 per 10,000.
The type of progestin paired with estrogen also matters. Older progestins like levonorgestrel consistently show lower clot rates than newer ones like desogestrel, gestodene, or drospirenone. This is why many guidelines recommend levonorgestrel-containing pills as a first choice for people concerned about clot risk.
Who Should Avoid Estrogen
Certain conditions make estrogen-containing contraception an unacceptable risk. The CDC classifies the following as absolute contraindications, meaning the risks clearly outweigh any benefit:
- Migraine with aura: combined pill use roughly triples the already elevated risk of ischemic stroke in people who get migraines with visual or sensory aura
- History of stroke or heart disease
- Severe high blood pressure (systolic 160 or above, or diastolic 100 or above)
- Vascular disease
- Smoking over age 35
For people in these categories, progestin-only methods (the mini-pill, hormonal IUDs, the implant, or the injection) provide contraception without the estrogen-related cardiovascular risks. If you have migraines without aura, or controlled mild hypertension, the decision is more nuanced and depends on your full health picture.